Friedenthal Financial »

Halozyme Therapeutics shares owned by Friedenthal Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Friedenthal Financial from 13F filings

Historical chart of Friedenthal Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Friedenthal Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Friedenthal Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $763k 13k 57.24

More positions owned by Friedenthal Financial

Ishares Tr CORE Samp;P TTL STK (ITOT)
Ishares Msci Emerg Mrkt (EEMV)
Ishares Tr Msci Eafe Min Vl (EFAV)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Pfd And Incm Sec (PFF)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Invesco Exchange Traded Fd T Samp;P500 EQL MAT (RSPM)
Select Sector Spdr Tr Communication (XLC)
Invesco Exchange Traded Fd T Samp;P500 EQL HLT (RSPH)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)

View all positions for Friedenthal Financial

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics